Study details
Enrolling now
Rapamycin Trial for Memory Problems
The University of Texas Health Science Center at San Antonio
NCT IDNCT04629495ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
40
Study length
about 4.6 years
Ages
55–89
Locations
1 site in TX
About this study
This trial is testing the safety of rapamycin, a drug, in older adults with memory problems. The goal is to see if this treatment can be safely given and how well it works over 1693 days.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take Rapamycin
PhasePhase 2
DrugRapamycin
Primary goalNumber of adverse events
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low14%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
sirolimus
Endpoints
Primary: Number of adverse events
Secondary: Change in Functional status, Change in Gait Speed, Change in Grip Strength, Change in Neuropsychiatric symptoms
Body systems
Neurology